home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

69 rows where docket_id = "FDA-2010-P-0614" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 2

  • 2011 64
  • 2010 5

document_type 2

  • Supporting & Related Material 61
  • Other 8

agency_id 1

  • FDA 69
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2010-P-0614-0079 FDA None FDA-2010-P-0614 Attachment 1 - "Supporting Research and Development to Promote Economic Growth: The Federal Government's Role" - [Mutual Pharmaceutical Company, Inc., (Sidley Austin LLP) - Reply Comment] Supporting & Related Material Reply Comment (RC) 2011-06-21T04:00:00Z 2011 6     2011-06-21T15:21:02Z   0 0 0900006480d0391b
FDA-2010-P-0614-0080 FDA None FDA-2010-P-0614 Attachment 2 - "Frequently Asked Questions About Drug Shortage" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material Reply Comment (RC) 2011-06-21T04:00:00Z 2011 6     2011-06-21T15:21:02Z   0 0 0900006480d0391c
FDA-2010-P-0614-0081 FDA None FDA-2010-P-0614 Attachment 3 - "Questions and Answers: Delayed-Release Pancreatic Enzyme Product Receives FDA Approval" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material Reply Comment (RC) 2011-06-21T04:00:00Z 2011 6     2011-06-21T15:21:02Z   0 0 0900006480d0391d
FDA-2010-P-0614-0077 FDA None FDA-2010-P-0614 Attachment 6 - "StatCrunch re FMF: Patients' Responses to Colchine, February 22, 2010" Supporting & Related Material Reply Comment (RC) 2011-06-17T04:00:00Z 2011 6     2011-06-17T22:54:24Z   0 0 0900006480c7a19f
FDA-2010-P-0614-0075 FDA None FDA-2010-P-0614 Attachment 4 - "e-Correspondence, re Westward, etc., December 15, 2009" Supporting & Related Material Reply Comment (RC) 2011-06-17T04:00:00Z 2011 6     2011-06-17T22:47:45Z   0 0 0900006480c79c28
FDA-2010-P-0614-0076 FDA None FDA-2010-P-0614 Attachment 5 - "e-Correspondence re Colchicine Assistance Program, February 22, 2010" Supporting & Related Material Reply Comment (RC) 2011-06-17T04:00:00Z 2011 6     2011-06-17T22:47:45Z   0 0 0900006480c79c29
FDA-2010-P-0614-0074 FDA None FDA-2010-P-0614 Attachment 2 - "Declaration and Curriculum Vitae, Dr. Thomas J. Maronick, DBA, JD" Supporting & Related Material Reply Comment (RC) 2011-06-17T04:00:00Z 2011 6     2011-06-17T22:47:44Z   0 0 0900006480c79c26
FDA-2010-P-0614-0072 FDA None FDA-2010-P-0614 FDA/CDER to Sidley Austin LLP - Petition Partial Approval and Denial Other PPAD-Petition Partial Approval and Denial 2011-05-25T04:00:00Z 2011 5 2011-05-25T04:00:00Z   2013-07-27T23:54:06Z   0 0 0900006480e3245f
FDA-2010-P-0614-0070 FDA None FDA-2010-P-0614 Appendix 2 - "American College of Rheumatory to FDA re huge price increases in the Colchicine Market, December 18, 2009" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] re FDA-2010-P-0614-0069 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-05-17T04:00:00Z 2011 5     2011-05-17T21:25:51Z   0 0 0900006480c79ac3
FDA-2010-P-0614-0071 FDA None FDA-2010-P-0614 Appendix 3 - "Summary of January 21 Teleconference with FDA Regarding Colchicine" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] re FDA-2010-P-0614-0069 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-05-17T04:00:00Z 2011 5     2011-05-17T21:26:28Z   0 0 0900006480c79ac4
FDA-2010-P-0614-0069 FDA None FDA-2010-P-0614 West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement Other SUP-Supplement 2011-05-17T04:00:00Z 2011 5 2011-05-17T04:00:00Z   2013-07-27T23:52:55Z   0 0 0900006480c79ac1
FDA-2010-P-0614-0067 FDA None FDA-2010-P-0614 Appendix 6 - "Qualaquin, URL Pharma" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-05-10T04:00:00Z 2011 5     2011-05-10T22:29:16Z   0 0 0900006480c40c2f
FDA-2010-P-0614-0062 FDA None FDA-2010-P-0614 Appendix 1 - "Motion to Dismiss, King Pharmaceuticals, Inc., and Jones Pharma, Inc., v. FDA, et al., US District Court for the District of Columbia, No.1:04cv01058(RBW)" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-05-10T04:00:00Z 2011 5     2011-05-10T22:04:49Z   0 0 0900006480c40c2a
FDA-2010-P-0614-0063 FDA None FDA-2010-P-0614 Appendix 2 - "Colchicine, E-mail Message, February 23, 2011" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-05-10T04:00:00Z 2011 5     2011-05-10T22:14:55Z   0 0 0900006480c40c2b
FDA-2010-P-0614-0065 FDA None FDA-2010-P-0614 Appendix 4 - "Patent Information Submitted Upon and After Approval of an NDA or Supplement, Form FDA 3542" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-05-10T04:00:00Z 2011 5     2011-05-10T22:18:16Z   0 0 0900006480c40c2d
FDA-2010-P-0614-0066 FDA None FDA-2010-P-0614 Appendix 5 - "Complaint for Declaratory Judgement, Mutual Pharmaceutical Company v. West-Ward Pharmaceutical Corporation, April 21, 2011" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-05-10T04:00:00Z 2011 5     2011-05-10T22:24:52Z   0 0 0900006480c40c2e
FDA-2010-P-0614-0061 FDA None FDA-2010-P-0614 West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement Other SUP-Supplement 2011-05-10T04:00:00Z 2011 5     2013-08-11T04:45:41Z   0 0 0900006480c40772
FDA-2010-P-0614-0064 FDA None FDA-2010-P-0614 Appendix 3 - "U.S. Patent Nos. 7,619,004 and 7,820,681" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-05-10T04:00:00Z 2011 5     2011-05-10T22:14:19Z   0 0 0900006480c40c2c
FDA-2010-P-0614-0058 FDA None FDA-2010-P-0614 Tab 20 - "FDA/CDER Chemistry Review(s) for NDA 21-342, Levo-T® (levothyroxine sodium tablets, USP)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:42Z   0 0 0900006480c2b452
FDA-2010-P-0614-0048 FDA None FDA-2010-P-0614 Tab 10 - "FDA News Release: FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:23Z   0 0 0900006480c263c4
FDA-2010-P-0614-0054 FDA None FDA-2010-P-0614 Tab 16 - "FDA/CDER Response to Pennie & Edmonds, LLP, Oct. 1, 2003" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:35Z   0 0 0900006480c27c69
FDA-2010-P-0614-0042 FDA None FDA-2010-P-0614 Tab 1 - "Transcript of FDA's Marketed Unapproved Drug Workshop, Pages 278-279, (Jan. 9, 2007)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:11Z   0 0 0900006480c2617a
FDA-2010-P-0614-0043 FDA None FDA-2010-P-0614 Tab 3 - "FDA/CDER Summary Review for Regulatory Action for NDA 22-353, Colcrys" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:13Z   0 0 0900006480c2617c
FDA-2010-P-0614-0049 FDA None FDA-2010-P-0614 Tab 11 - "Package Insert for Probenecid and Colchicine Tablets (Watson Laboratories, Inc.)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:25Z   0 0 0900006480c26b62
FDA-2010-P-0614-0044 FDA None FDA-2010-P-0614 Tab 5 - "Approved Product Labeling for Colchicine Tablet (Rebel Distributors Corp.)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:15Z   0 0 0900006480c2617e
FDA-2010-P-0614-0045 FDA None FDA-2010-P-0614 Tab 6 - "Approved Product Labeling for Colchicine Tablet (RemedyRepack, Inc.)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:17Z   0 0 0900006480c2617f
FDA-2010-P-0614-0051 FDA None FDA-2010-P-0614 Tab 13 - "FDA/CDER Administrative and Correspondence Documents Related to NDA 22-353, Colcrys" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:29Z   0 0 0900006480c27c66
FDA-2010-P-0614-0055 FDA None FDA-2010-P-0614 Tab 17 - "FDA/CDER Chemistry Review(s) for NDA 21-116, Thyro-Tabs® (levothyroxine sodium tablets, USP)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:36Z   0 0 0900006480c27c6a
FDA-2010-P-0614-0046 FDA None FDA-2010-P-0614 Tab 7 - "Approved Prescribing Information for Colchicine (Colchicine Tablet) (West-ward Pharmaceutical Corp.)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:19Z   0 0 0900006480c263bf
FDA-2010-P-0614-0050 FDA None FDA-2010-P-0614 Tab 12 - "FDA/CDER Cross Discipline Team Leader Review of NDA 22-353, Colcrys (Colchicine)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:27Z   0 0 0900006480c27c63
FDA-2010-P-0614-0060 FDA None FDA-2010-P-0614 Tab 23 - "FDA/CDER Cross Discipline Team Leader Review for NDA 22-351, Colcrys (colchicine)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:46Z   0 0 0900006480c2b455
FDA-2010-P-0614-0047 FDA None FDA-2010-P-0614 Tab 9 - "Disclosure of FOIA Request Log for Control No. 2009-6835, August 26, 2009 " - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:21Z   0 0 0900006480c263c3
FDA-2010-P-0614-0052 FDA None FDA-2010-P-0614 Tab 14 - "FDA/CDER Response to Osmotica Pharmaceutical Corp., Nov. 25, 2008" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:31Z   0 0 0900006480c27c67
FDA-2010-P-0614-0057 FDA None FDA-2010-P-0614 Tab 19 - "FDA/CDER Chemistry Review(s) for NDA 21-402, Synthroid® (levothyroxine sodium tablets, USP)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:40Z   0 0 0900006480c27c6c
FDA-2010-P-0614-0059 FDA None FDA-2010-P-0614 Tab 22 - "Chemistry Review(s) for NDA 21-137, Levolet® (levothyroxine sodium tablets, USP)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:44Z   0 0 0900006480c2b454
FDA-2010-P-0614-0056 FDA None FDA-2010-P-0614 Tab 18 - "FDA/CDER Chemistry Review(s) for NDA 21-292, Novothyrox (levothyroxine sodium tablet, USP)" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:38Z   0 0 0900006480c27c6b
FDA-2010-P-0614-0053 FDA None FDA-2010-P-0614 Tab 15 - "FDA/CDER Response to Osmotica Pharmaceutical Corp., Jan. 21, 2010" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2011-04-27T04:00:00Z 2011 4     2011-04-27T19:20:33Z   0 0 0900006480c27c68
FDA-2010-P-0614-0033 FDA None FDA-2010-P-0614 Appendix 11 - "November 20, 2004 Letter From Galson (FDA) to Beers and Cavanaugh Regarding Docket No. 2004P-0386" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T22:42:11Z   0 0 0900006480c2da29
FDA-2010-P-0614-0030 FDA None FDA-2010-P-0614 Appendix 8 - "Draft Guidance for Industry: Application Covered by Section 505(b)(2), (October 1999)" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T22:34:11Z   0 0 0900006480c2da11
FDA-2010-P-0614-0041 FDA None FDA-2010-P-0614 Appendix 21 - "Rockoff, An Old Gout Drug Gets New Life an a New Price, Riling Patients, Drug, July 7, 2010" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T23:32:51Z   0 0 0900006480c2e382
FDA-2010-P-0614-0037 FDA None FDA-2010-P-0614 Appendix 17 - "Teva Pharms., USA, Inc. v. FDA, 182 F. 3d 1003, (D.C. Cir.1999)- [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T23:04:16Z   0 0 0900006480c2e19a
FDA-2010-P-0614-0038 FDA None FDA-2010-P-0614 Appendix 18 - "Civil Minutes From Mutual Pharm. Co, Inc. v. West-Ward Pharm. Corp. Et al, Civ. Action 09-05700 (C.D. Cal. 2010)" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T23:06:40Z   0 0 0900006480c2e19b
FDA-2010-P-0614-0039 FDA None FDA-2010-P-0614 Appendix 20 - "Miller, The Price of Gout Drug Colchicine, Goes Up, April 20, 2010" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T23:11:25Z   0 0 0900006480c2e381
FDA-2010-P-0614-0036 FDA None FDA-2010-P-0614 Appendix 14 - "Redacted Letter From Chowdhury (FDA) to West-Ward Pharmaceutical Corporation" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T22:55:46Z   0 0 0900006480c2e197
FDA-2010-P-0614-0032 FDA None FDA-2010-P-0614 Appendix 10 - "FDA, Clinical Review for NDA 22-353" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T22:41:47Z   0 0 0900006480c2da28
FDA-2010-P-0614-0031 FDA None FDA-2010-P-0614 Appendix 9 - "FDA, Summary Review for Regulatory Action for NDA 22-353" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T22:36:17Z   0 0 0900006480c2da12
FDA-2010-P-0614-0034 FDA None FDA-2010-P-0614 Appendix 12 - "August 1, 2008 Letter from Mutual Pharmaceutical Company, Inc. re: Citizen Petition Submission (Docket No. FDA-2008-P-0442)" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T22:45:19Z   0 0 0900006480c2e0ac
FDA-2010-P-0614-0028 FDA None FDA-2010-P-0614 West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement Other SUP-Supplement 2011-04-22T04:00:00Z 2011 4 2011-04-22T04:00:00Z   2013-07-27T23:50:28Z   0 0 0900006480c2d939
FDA-2010-P-0614-0035 FDA None FDA-2010-P-0614 Appendix 13 - "December 18, 2009 Letter from Stanley Cohen, MD to Janet Woodcock re: Removal of Unapproved Colchicine" - [West-Ward Pharmaceutical Group (Arnall Golden Gregory LLP) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-04-22T04:00:00Z 2011 4     2011-04-22T22:53:40Z   0 0 0900006480c2e196
FDA-2010-P-0614-0026 FDA None FDA-2010-P-0614 Janine Jagger, M.P.H., Ph.D., to FDA - Letter Other LET-Letter 2011-04-11T04:00:00Z 2011 4 2011-04-11T04:00:00Z   2013-08-11T01:40:49Z   0 0 0900006480c18eec
FDA-2010-P-0614-0023 FDA None FDA-2010-P-0614 Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) to FDA/CDER - Letter Other LET-Letter 2011-03-18T04:00:00Z 2011 3 2011-03-18T04:00:00Z   2013-07-27T23:46:50Z   0 0 0900006480c025de
FDA-2010-P-0614-0019 FDA None FDA-2010-P-0614 Tab 16 - "FDA Administrative and Correspondence Documents for NDA 22-351: Minutes from Type B Pre-IND Meeting Between FDA and Mutual Pharmaceutical Company, Inc.," July 31, 2006 - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:15Z   0 0 0900006480bc1b4c
FDA-2010-P-0614-0011 FDA None FDA-2010-P-0614 Tab 6 - FDA Information for Healthcare Professionals, "New Safety Information for Colchicine (Marketed as Colcrys)," July 30, 2009 - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:02Z   0 0 0900006480bc1ae1
FDA-2010-P-0614-0014 FDA None FDA-2010-P-0614 Tab 9 - "Letter from FDA's Center for Drug Evaluation and Research to Osmotica Pharmaceutical Corp. regarding Docket No. FDA-2008-P-0329," dated November 25, 2008 - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:07Z   0 0 0900006480bc1ae4
FDA-2010-P-0614-0008 FDA None FDA-2010-P-0614 Tab 1 - FDA Consumer Information, "New Label Information Affecting All Approved Protease Inhibitors for Treatment of HIV" - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:30:41Z   0 0 0900006480bc1745
FDA-2010-P-0614-0012 FDA None FDA-2010-P-0614 Tab 7 - "Letter from FDA's Center for Drug Evaluation and Research to Arnold & Porter, LLP and Patterson, Belknap, Webb & Tyler, LLP regarding Docket No. 2004P-0386," dated November 30, 2004 - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:03Z   0 0 0900006480bc1ae2
FDA-2010-P-0614-0015 FDA None FDA-2010-P-0614 Tab 12 - "Allopurinol Package Insert" - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:09Z   0 0 0900006480bc1ae9
FDA-2010-P-0614-0017 FDA None FDA-2010-P-0614 Tab 14 - "FDA Clinical Review for NADA 22-353" dated August 5, 2009 (Relevant Pages) - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:12Z   0 0 0900006480bc1b48
FDA-2010-P-0614-0018 FDA None FDA-2010-P-0614 Tab 15 - "FDA Clinical Pharmacology and Biopharmaceutics Review(s) for NDA 22-352," dated November 26, 2008 (Relevant Pages) - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:14Z   0 0 0900006480bc1b4b
FDA-2010-P-0614-0010 FDA None FDA-2010-P-0614 Tab 3 - "Declaration of E. Marro in Support of Defendant West-Ward Pharmaceutical Corp.'s Response in Opposition to Plaintiff's Motion for Preliminary Injunction" - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:00Z   0 0 0900006480bc1908
FDA-2010-P-0614-0016 FDA None FDA-2010-P-0614 Tab 13 - "Letter from FDA's Center for Drug Evaluation and Research to Covington & Burling (Wyeth Pharmaceuticals) regarding Docket No. 2003P-0518" dated September 20, 2004 - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:10Z   0 0 0900006480bc1b45
FDA-2010-P-0614-0009 FDA None FDA-2010-P-0614 Tab 2 - "Open Letter from FDA's Center for Drug Evaluation and Research regarding Unapproved Colchicine" - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:33:58Z   0 0 0900006480bc1906
FDA-2010-P-0614-0013 FDA None FDA-2010-P-0614 Tab 8 - "Letter from FDA's Center for Drug Evaluation and Research to Sanzo, et. al., regarding Docket Nos. 2001P-0323, 2002P-0447, and 2003P-0408," dated October 14, 2004 - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2011-01-20T05:00:00Z 2011 1     2011-01-20T17:34:05Z   0 0 0900006480bc1ae3
FDA-2010-P-0614-0007 FDA None FDA-2010-P-0614 Sidley Austin, LLP [Mutual Pharmaceutical Company, Inc.] - Supplement Other SUP-Supplement 2011-01-19T05:00:00Z 2011 1 2011-01-19T05:00:00Z   2013-08-11T03:12:27Z   0 0 0900006480bc1744
FDA-2010-P-0614-0004 FDA None FDA-2010-P-0614 Attachment 2 Highlights of Prescribing Information [Mutual Pharmaceutical Company, Inc. Citizen petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-08T05:00:00Z 2010 12     2010-12-08T21:18:40Z   0 0 0900006480baa7f3
FDA-2010-P-0614-0006 FDA None FDA-2010-P-0614 Attachment 4 Letter From Center for Drugs [Mutual Pharmaceutical Company, Inc. Citizen petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-08T05:00:00Z 2010 12     2010-12-08T21:18:13Z   0 0 0900006480baa852
FDA-2010-P-0614-0001 FDA None FDA-2010-P-0614 Acknowledgement Letter to Sidley Austin LLP [Mutual Pharmaceutical Company, Inc.] Other ACK-Acknowledgement Letter 2010-12-08T05:00:00Z 2010 12 2010-12-08T05:00:00Z   2010-12-08T21:01:59Z   0 0 0900006480baa855
FDA-2010-P-0614-0003 FDA None FDA-2010-P-0614 Attachment 1 Colchicine Tablets USP [Mutual Pharmaceutical Company, Inc. Citizen petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-08T05:00:00Z 2010 12     2024-11-12T05:00:59Z   0 0 0900006480baa773
FDA-2010-P-0614-0005 FDA None FDA-2010-P-0614 Attachment 3 Marion Merrell Dow, Inc. et al Plaintiffs, V. Hoechst-Roussel Pharmaceuticals, Inc. Defendant [Mutual Pharmaceutical Company, Inc. Citizen petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-08T05:00:00Z 2010 12     2010-12-08T21:16:39Z   0 0 0900006480baa774

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 761.281ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API